1. Home
  2. HTCR vs ADIL Comparison

HTCR vs ADIL Comparison

Compare HTCR & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

HOLD

Current Price

$3.30

Market Cap

6.5M

Sector

Technology

ML Signal

HOLD

Logo Adial Pharmaceuticals Inc

ADIL

Adial Pharmaceuticals Inc

HOLD

Current Price

$1.58

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTCR
ADIL
Founded
2009
2010
Country
Japan
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.4M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
HTCR
ADIL
Price
$3.30
$1.58
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$37.50
AVG Volume (30 Days)
218.6K
71.7K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
81.76%
N/A
EPS Growth
414.29
N/A
EPS
0.22
N/A
Revenue
$30,407,229.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
N/A
P/E Ratio
$14.45
N/A
Revenue Growth
39.19
N/A
52 Week Low
$0.15
$0.13
52 Week High
$3.97
$3.67

Technical Indicators

Market Signals
Indicator
HTCR
ADIL
Relative Strength Index (RSI) 74.09 41.27
Support Level $0.42 $0.29
Resistance Level $3.97 $1.89
Average True Range (ATR) 0.26 0.11
MACD 0.28 -0.02
Stochastic Oscillator 82.19 8.57

Price Performance

Historical Comparison
HTCR
ADIL

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

Share on Social Networks: